Clik here to view.
Pharmaceutical Compliance Congress: A Preview
The 16th Pharmaceutical Compliance Congress and Best Practices Forum kicks off Wednesday and the PharmaCertify™ team is looking forward to a variety of speakers and sessions. Here are just a few at...
View ArticleClik here to view.
The 2015 Pharmaceutical Compliance Congress: A Review
The Sixteenth Annual Pharmaceutical Regulatory and Compliance Congress, in Washington DC, featured legislators and industry leaders discussing hot topics and best practices to a diverse and rapt...
View ArticleClik here to view.
Compliance News in Review, November 2, 2015
The first corporate criminal bribery settlement under the UK Bribery Act is announced, a Biomet rep files a retaliation suit under the False Claims Act, Novartis settles with the DOJ, Warner Chilcott...
View ArticleClik here to view.
Compliance News in Review, November 16, 2015
The OIG 2016 Work Plan is released, the House of Representatives form a task force to combat rising drug costs, a Massachusetts HCP is indicted in the Warner Chilcott case, and CMS releases...
View ArticleClik here to view.
Compliance News in Review, November 24, 2015
The new nominee to head the FDA faces some tough questions on Capitol Hill, state prosecutors join to investigate potential false claims made by pharmacies, and the AMA institutes a policy calling for...
View ArticleClik here to view.
Compliance News in Review, December 10, 2015
One of the great traditions of the Christmas season is the performance of Tchaikovsky’s The Nutcracker by ballet companies and dance schools around the world. Whether performed by professionals or...
View ArticleClik here to view.
The 2015 Compliance Year in Review (and Look Forward to the Rest of 2016)
The start of 2016 may be filled with hope for good compliance-related news to come, but before we travel too far forward with our prognostications, let’s take a look back at some of the stories that...
View ArticleClik here to view.
Compliance News in Review, February 1, 2016
It’s Super Bowl week! Another season of ups, downs, highlights, lowlights, hope, and unfulfilled expectations for fans around the country (except for those lucky enough to root for the winning squad)...
View ArticleClik here to view.
Compliance News in Review, February 15, 2016
Ah, l’amour! It is the stuff of literature, song, poetry, and this time of year, greeting cards galore. Some might refer to Valentine’s Day as a “Hallmark Holiday,” but any day that makes the...
View ArticleClik here to view.
Compliance News in Review, February 23, 2016
Did you feel the awakening? It was as if a million voices cried out in joy, then were suddenly, silently going about their business again. Geekerati rejoice! The Star Wars: Episode VII video announcing...
View ArticleClik here to view.
Compliance Buzz™ February 29, 2016: Three observations from OPDP Notice of...
Welcome to the first issue of PharmaCertify Compliance Buzz™! From Corporate Integrity Agreements to FDA guidance documents, the material published by government enforcement entities offers valuable...
View ArticleClik here to view.
Compliance News in Review, March 8, 2016
A bill is introduced in the Senate to end DTC advertising, Endo settles with New York over alleged marketing violations, and Olympus settles multiple False Claims Act, Anti0kickback, and FCPA charges....
View ArticleClik here to view.
Compliance Buzz March 14, 2016 – Three Good Reasons to Pre-Disclose HCP Spend
To pre-disclose, or not to pre-disclose. That is the question. Life science staffs are juggling multiple HCP spend transparency disclosure requirements these days. Managing those requirements can be a...
View ArticleClik here to view.
Compliance News in Review, Ides of March Edition
BMS makes changes to its promotional spend policy in China, a physician is sentenced to prison for accepting kickbacks, and the FDA agrees to allow Amarin to promote its fish oil drug for off-label...
View ArticleClik here to view.
Compliance News in Review, March 29, 2016
New anti-corruption measures are introduced in Australia, the FDA announces a new requirement for opioid labels, PhRMA is sending researchers to Capitol Hill, and Respironics settles False Claims...
View ArticleClik here to view.
The 2016 Pharmaceutical Compliance Congress: a Preview
On April 26 and 27, compliance professionals and government representatives will gather in Washington, D.C. for the 13th Annual Pharmaceutical Compliance Congress. As usual, the conference offers a...
View ArticleClik here to view.
Compliance News in Review, April 13, 2016
Industry companies in Canada announce plans to voluntarily disclose payment data. Massachusetts institutes new disclosure requirements, the DOJ offers smaller penalties in exchange for self-reporting,...
View ArticleClik here to view.
Compliance Edutrainment: Too Much of a Good Thing?
These days, the standard airline safety presentation is delivered via video on most aircraft. Somewhere along the way, airlines decided this approach was an opportunity to express their creative...
View ArticleClik here to view.
News and Notes from the 13th Annual Pharmaceutical Compliance Congress
CBI’s 13th Annual Pharmaceutical Compliance Congress, held last week at the Ritz-Carlton in Washington DC, offered an impressive lineup of industry luminaries and government regulators discussing a...
View ArticleClik here to view.
Compliance News in Review – In Case You Missed It, April 2016
Wow, we’re already a week into May 2016. Time flies when you’re staying compliant. If policy writing, auditing, monitoring, or compliance training development kept you too busy to keep up with all of...
View Article